Brain-Cortex Microglia-Derived Exosomes: Nanoparticles for Glioma Therapy - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue ChemPhysChem Année : 2018

Brain-Cortex Microglia-Derived Exosomes: Nanoparticles for Glioma Therapy

Résumé

The function and integrity of the nervous system require interactive exchanges among neurons and glial cells. Exosomes and other extracellular vesicles (EVs) are emerging as a key mediator of intercellular communication, capable of transferring nucleic acids, proteins and lipids influencing numerous functional and pathological aspects of both donor and recipient cells. The immune response mediated by microglia-derived exosomes is most prominently involved in the spread of neuroinflammation, neurodegenerative disorders, and brain cancer. Therefore, in the present study we describe a reproducible and highly efficient method for yielding purified primary microglia cells, followed by exosome isolation and their characterization. An in vitro biological assay demonstrates that microglia-derived exosomes tested on a 3D spheroid glioma culture were able to inhibit tumor invasion in time course. These results evidence that brain microglia-derived exosomes could be used as nanotherapeutic agents against glioma cells.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-02940806 , version 1 (16-09-2020)

Identifiants

Citer

Adriana-Natalia Murgoci, Dasa Cizkova, Petra Majerova, Eva Petrovova, Lubomir Medvecky, et al.. Brain-Cortex Microglia-Derived Exosomes: Nanoparticles for Glioma Therapy. ChemPhysChem, 2018, 19 (10), pp.1205-1214. ⟨10.1002/cphc.201701198⟩. ⟨inserm-02940806⟩

Collections

INSERM UNIV-LILLE
25 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More